RITUXAN (Rituximab) drug information from MPR
Links shared publicly online about this topic.
- 131total visits
RITUXAN (Rituximab) drug information from MPR
empr.com —
RITUXAN (Rituximab) drug information for Microscopic polyangitis, Wegener's granulomatosis from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.
View full resource at empr.com
Tags: Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, Vasculitis, Wegener Granulomatosis, Drug, Rituxan, MabThera, News
Most Recently Shared on July 21, 2011 at 6:02 am By:
MPR News: RITUXAN: Indications: approved for Wegener's granulomatosis and microscopic polyangiitis. http://bit.ly/mUJVDj
Advertisement
